Delivery Order SPE2DB22D1106-SPE2DB25FFEY9
Award Date 8/25/25
Potential Completion Date 9/16/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for supply of Envarsus XR 4 mg tablets (100 count) under a firm fixed price contract valued at $2,141.57. This delivery order represents a non-set-aside competitive award, with an ultimate completion date of September 3, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) under a firm fixed-price contract valued at $4,712.76, with completion targeted for September 10, 2025. This non-set-aside award represents a competitive procurement of pharmaceutical products to support federal healthcare needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical supplier within the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Envarsus XR 4 mg tablets (100-count) valued at $10,271.70 under firm fixed price terms. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 7, 2025. AmerisourceBergen will perform this work from its corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a $3,423.90 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Envarsus XR 4 mg tablets (100-count packages). This firm fixed price, non-set-aside contract is scheduled for completion by September 10, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs through the agency's established...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,711.95 on August 11, 2025, for the supply of Envarsus XR 4 mg tablets (100-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of September 2, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Envarsus XR 1 mg tablets in a quantity of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,718.48 with firm fixed pricing and is scheduled for completion by September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $2,148.10 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Envarsus XR 1 mg tablets (100-count). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 17, 2025, and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with federal medical procurement. The work will be performed at the company's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Envarsus XR 0.75 mg tablets (30-count) with a ceiling value of $2,339.52. This delivery order represents a competitive, firm fixed-price procurement with no set-aside designation and is scheduled for ultimate completion by September 17, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,711.95 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 4 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract represents a pharmaceutical supply delivery executed under a competitively awarded vehicle. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Envarsus XR 1 mg tablets (100-count units) with a ceiling value of $1,151.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 16, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside contract, this award reflects AmerisourceBergen's capability to compete...